dc.contributor.author | Yolli, H. | |
dc.contributor.author | Demir, M.E. | |
dc.contributor.author | Yildizhan, R. | |
dc.date.accessioned | 2021-12-21T08:40:42Z | |
dc.date.available | 2021-12-21T08:40:42Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 3906663 | |
dc.identifier.uri | https://doi.org/10.31083/J.CEOG.2020.04.5359 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1158 | |
dc.description.abstract | Objectives: Lipocalin-2 (LCN-2) is an immune modulator. It is highly associated with inflammation, ischemia, neoplastic invasion, and transformation. Preeclampsia (PE) is a pregnancy-related disease resulting from the incomplete invasion of trophoblasts. | |
dc.description.sponsorship | The study was supported by Van Yuzuncu Yil University the scientific research program. Thanks to all the peer reviewers and editors for their opinions and suggestions. | |
dc.language.iso | English | |
dc.publisher | IMR Press Limited | |
dc.rights | All Open Access, Bronze | |
dc.title | Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia | |
dc.type | Article | |
dc.relation.journal | Clinical and Experimental Obstetrics and Gynecology | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 519 | |
dc.identifier.endpage | 523 | |
dc.identifier.volume | 47 | |
dc.identifier.doi | 10.31083/J.CEOG.2020.04.5359 | |
dc.relation.issue | 4 | |
dc.relation.volume | 47 | |